Irisin in patients with nonalcoholic fatty liver disease.
Title | Irisin in patients with nonalcoholic fatty liver disease. |
Publication Type | Journal Article |
Year of Publication | 2014 |
Authors | Polyzos, S. A., Kountouras J., Anastasilakis A. D., Geladari E. V., & Mantzoros C. S. |
Journal | Metabolism |
Volume | 63 |
Issue | 2 |
Pagination | 207-17 |
Date Published | 2014 Feb |
ISSN | 1532-8600 |
Keywords | Adipokines, Adiponectin, Adult, Aged, Biomarkers, Body Mass Index, Case-Control Studies, Chemokines, Fatty Liver, Female, Fibronectins, Humans, Inflammation, Insulin Resistance, Intercellular Signaling Peptides and Proteins, Leptin, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, Obesity, Portal Vein, Retinol-Binding Proteins, Plasma, Risk Factors, Severity of Illness Index, Thinness |
Abstract | OBJECTIVE: Irisin is a recently discovered myokine proposed to increase thermogenesis-related energy expenditure and improve metabolism. We aimed to comparatively evaluate serum irisin levels in patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) vs. controls and study their association with disease severity. |
DOI | 10.1016/j.metabol.2013.09.013 |
Alternate Journal | Metab. Clin. Exp. |
PubMed ID | 24140091 |
Grant List | NIDDK 81913 / / PHS HHS / United States |